Related references
Note: Only part of the references are listed.Covalent Immune Recruiters: Tools to Gain Chemical Control Over Immune Recognition
Benjamin Lake et al.
ACS CHEMICAL BIOLOGY (2020)
Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses
Koichi Sasaki et al.
CHEMICAL SCIENCE (2020)
Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers
Annemiek Uvyn et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease
Jose D. Pagan et al.
CELL (2018)
A peptide inhibitor of antibody-dependent cell-mediated cytotoxicity against EGFR/folate receptor-α double positive cells
Koichi Sasaki et al.
MEDCHEMCOMM (2018)
Development of the Double Cyclic Peptide Ligand for Antibody Purification and Protein Detection
Yiyi Gong et al.
BIOCONJUGATE CHEMISTRY (2016)
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Madduri Srinivasarao et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells
Rachael T. C. Sheridan et al.
CHEMBIOCHEM (2014)
Fusion of a Short Peptide that Binds Immunoglobulin G to a Recombinant Protein Substantially Increases Its Plasma Half-Life in Mice
Jonathan T. Sockolosky et al.
PLOS ONE (2014)
Exploring Binding and Effector Functions of Natural Human Antibodies Using Synthetic Immunomodulators
Charles E. Jakobsche et al.
ACS CHEMICAL BIOLOGY (2013)
Structural basis for molecular recognition of folic acid by folate receptors
Chen Chen et al.
NATURE (2013)
Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease
Patrick J. McEnaney et al.
ACS CHEMICAL BIOLOGY (2012)
High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism
Yuji Mishima et al.
INTERNATIONAL IMMUNOLOGY (2012)
A Chemically Induced Vaccine Strategy for Prostate Cancer
Anna Dubrovska et al.
ACS CHEMICAL BIOLOGY (2011)
Introduction to current and future protein therapeutics: A protein engineering perspective
Paul J. Carter
EXPERIMENTAL CELL RESEARCH (2011)
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Tsunehiro Mizushima et al.
GENES TO CELLS (2011)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
Bohua Li et al.
BLOOD (2009)
Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer
Ryan P. Murelli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents
Sumith A. Kularatne et al.
MOLECULAR PHARMACEUTICS (2009)
Computational design of antibody-affinity improvement beyond in vivo maturation
Shaun M. Lippow et al.
NATURE BIOTECHNOLOGY (2007)
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Geertje M. Bartelds et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with β-phenylethyl isothiocyanate and curcumin
JH Kim et al.
CARCINOGENESIS (2006)
Protein aggregation and bioprocessing
Mary E. M. Cromwell et al.
AAPS JOURNAL (2006)
Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: Efficacy as analgesic agents
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa
A Okazaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
OH Brekke et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Design of NAALADase inhibitors: A novel neuroprotective strategy
PF Jackson et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
IE Eder et al.
CANCER GENE THERAPY (2000)
Share Paper
